Cardioprotective mechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type 1 receptor activation

被引:4
作者
Miki, T [1 ]
Miura, T [1 ]
Tsuchida, A [1 ]
Nakano, A [1 ]
Hasegawa, T [1 ]
Fukuma, T [1 ]
Shimamoto, K [1 ]
机构
[1] Hokkaido Univ, Sch Med, Dept Internal Med 2, Chuo Ku, Sapporo, Hokkaido 0608543, Japan
关键词
preconditioning; myocardial infarction; remodeling; angiotensin; receptors; ion channels;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Activation of protein kinase C-linked receptors and subsequent opening of the mitochondrial ATP-sensitive K+ (mitoK(ATP)) channel are crucial in preconditioning (PC). This study examined whether postinfarct ventricular remodeling interferes with the PC mechanism. Methods and Results-Two weeks before isolation of hearts, rabbits underwent a sham operation or coronary ligation (COL) to induce remodeling. Isolated buffer-perfused hearts were subjected to 30-minute global ischemia/2-hour reperfusion, and infarct size was expressed as a percentage of the left ventricle (%I/LV), from which the scarred infarct by COL was excluded. Although %I/LV was similar in sham-operated and remodeled hearts (52.9+/-6.5% versus 45.8+/-5.2%), PC with 2 episodes of 5-minute ischemia protected sham-operated but not remodeled hearts (%I/LV = 18.1+/-2.5% versus 54.8+/-2.9%, P<0.05). Infusion of valsartan (10 mg . kg(-1). d(-1)), an angiotensin II type 1 (AT,) receptor blocker, for 2 weeks after COL prevented the ventricular remodeling and preserved the response to PC (%I/LV=27.4+/-3.8%), although valsartan alone did not change %I/LV. Diazoxide, a mitoK(ATP) channel opener, protected both sham-operated and remodeled hearts (%I/LV=14.1+/-3.1% and 8.36+/-3.6%). Conclusions-The myocardium remodeled after infarction is refractory to PC, which is probably due to interruption of cellular signaling by PC upstream of mitoK(ATP) channels. An AT(1) receptor blocker is beneficial not only for suppression of ventricular remodeling but also for preservation of the PC mechanism.
引用
收藏
页码:458 / 463
页数:6
相关论文
共 31 条
[1]   Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium [J].
Baines, CP ;
Goto, M ;
Downey, JM .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (01) :207-216
[2]   Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart [J].
Baines, CP ;
Wang, L ;
Cohen, MV ;
Downey, JM .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1998, 30 (02) :383-392
[3]   Ischemic preconditioning depends on interaction between mitochondrial KATP channels and actin cytoskeleton [J].
Baines, CP ;
Liu, GS ;
Birincioglu, M ;
Critz, SD ;
Cohen, MV ;
Downey, JM .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1999, 276 (04) :H1361-H1368
[4]   Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy [J].
Bogoyevitch, MA ;
Andersson, MB ;
GillespieBrown, J ;
Clerk, A ;
Glennon, PE ;
Fuller, SJ ;
Sugden, PH .
BIOCHEMICAL JOURNAL, 1996, 314 :115-121
[5]   INCREASE OF GI-ALPHA IN HUMAN HEARTS WITH DILATED BUT NOT ISCHEMIC CARDIOMYOPATHY [J].
BOHM, M ;
GIERSCHIK, P ;
JAKOBS, KH ;
PIESKE, B ;
SCHNABEL, P ;
UNGERER, M ;
ERDMANN, E .
CIRCULATION, 1990, 82 (04) :1249-1265
[6]   RELATION OF INITIAL INFARCT SIZE TO EXTENT OF LEFT-VENTRICULAR REMODELING IN THE YEAR AFTER ACUTE MYOCARDIAL-INFARCTION [J].
CHAREONTHAITAWEE, P ;
CHRISTIAN, TF ;
HIROSE, K ;
GIBBONS, RJ ;
RUMBERGER, JA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (03) :567-573
[7]   Naloxone blockade of myocardial ischemic preconditioning does not require central nervous system participation [J].
Chien, GL ;
Mohtadi, K ;
Wolff, RA ;
Van Winkle, DM .
BASIC RESEARCH IN CARDIOLOGY, 1999, 94 (02) :136-143
[8]   Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: A role in cardiac myocyte hypertrophy? [J].
Clerk, A ;
Michael, A ;
Sugden, PH .
JOURNAL OF CELL BIOLOGY, 1998, 142 (02) :523-535
[9]   BINDING OF VALSARTAN TO MAMMALIAN ANGIOTENSIN AT(1) RECEPTORS [J].
DEGASPARO, M ;
WHITEBREAD, S .
REGULATORY PEPTIDES, 1995, 59 (03) :303-311
[10]  
Garlid KD, 1997, CIRC RES, V81, P1072